The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study. | 2024 | Frontiers in Neurology |
A comparison of cenobamate with other newer antiseizure medications for adjunctive treatment of focal-onset seizures: a systematic review and network meta-analysis. | 2024 | Seizure |
Efficacy and tolerability of lacosamide in lennox–gastaut syndrome: a systematic review and meta-analysis. | 2022 | Journal of Neurosciences in Rural Practice |
Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures. | 2022 | Epilepsy and Behavior |
Third-generation antiseizure medications for adjunctive treatment of focal-onset seizures in adults: a systematic review and network meta-analysis. | 2022 | Drugs |
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. | 2022 | The Cochrane Database of Systematic Reviews |
Movement disorders secondary to novel antiseizure medications in pediatric populations: a systematic review and meta-analysis of risk. | 2022 | Journal of Child Neurology |
Efficacy of lacosamide and phenytoin in status epilepticus: a systematic review. | 2021 | Acta Neurologica Scandinavica |
Lacosamide add-on therapy for focal epilepsy. | 2021 | The Cochrane Database of Systematic Reviews |
Clinical efficacy and safety of lacosamide as an adjunctive treatment in adults with refractory epilepsy. | 2021 | Frontiers in Neurology |
Anti-seizure medications and efficacy against focal to bilateral tonic-clonic seizures: a systematic review with relevance for SUDEP prevention. | 2021 | Epilepsy and Behavior |